Kudo, Masatoshi

Publishing since 2002 (Junior)

Has published 216 publications in 9 years

Number of publications published per year by Kudo, Masatoshi. (Source : PubMed)

Distribution of publications types for Kudo, Masatoshi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.  AJR Am J Roentgenol  2010;194;3  
•  Kawase R, Ishiwata T, Matsuda Y, Onda M, Kudo M, Takeshita T, Naito Z. Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer.  Int. J. Oncol.  2010;36;2  
•  Inoue S, Watanuki Y, Miyazawa N, Kudo M, Sato T, Kobayashi N, Mishina K, Sasaki M, Kaneko T, Ishigatsubo Y. High frequency of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae in patients with chronic bronchitis in Japan.  J. Infect. Chemother.  2010  
•  Tatsumi C, Kudo M, Ueshima K, Kitai S, Ishikawa E, Yada N, Hagiwara S, Inoue T, Minami Y, Chung H, Maekawa K, Fujimoto K, Kato M, Tonomura A, Mitake T, Shiina T. Non-invasive evaluation of hepatic fibrosis for type C chronic hepatitis.  Intervirology  2010;53;1  
•  Yuuki S, Komatsu Y, Fuse N, Kato T, Miyagishima T, Kudo M, Watanabe M, Tateyama M, Kunieda Y, Wakahama O, Sakata Y, Asaka M. Modified-Irinotecan/Fluorouracil/Levoleucovorin Therapy as Ambulatory Treatment for Metastatic Colorectal Cancer: Results of Phase I and II Studies.  Clin Drug Investig  2010;30;4  
•  Yada N, Kudo M, Chung H, Hayaishi S, Takita M, Ueda T, Tatsumi C, Hatanaka K, Kitai S, Ishikawa E, Inoue T, Hagiwara S, Ueshima K. PEG-IFNalpha/RBV combination therapy for chronic hepatitis C patients increases serum ferritin level while it improves sustained viral response rate.  Intervirology  2010;53;1  
•  Ueda T, Chung H, Kudo M, Ishikawa E, Hayaishi S, Tatsumi C, Inoue T, Yada N, Hagiwara S, Minami Y, Ueshima K. Prolonged PEG-IFN and RBV is effective in patients with HCV genotype 1 and high viral load who achieved virological response later than 24 weeks.  Intervirology  2010;53;1  
•  Sasase N, Kim SR, Kudo M, Kim KI, Taniguchi M, Imoto S, Mita K, Hayashi Y, Shoji I, El-Shamy A, Hotta H. Outcome and early viral dynamics with viral mutation in PEG-IFN/RBV therapy for chronic hepatitis in patients with high viral loads of serum HCV RNA genotype 1b.  Intervirology  2010;53;1  
•  Kim SR, Imoto S, Kudo M, Mita K, Taniguchi M, Kim KI, Sasase N, Shoji I, Nagano-Fujii M, El-Shamy A, Hotta H, Nagai T, Nagata Y, Hayashi Y. Double-filtration plasmapheresis plus IFN for HCV-1b patients with non-sustained virological response to previous combination therapy: early viral dynamics.  Intervirology  2010;53;1  
•  Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan.  Intervirology  2010;53;1  

[ See timeline ] [ See all publications ]